Carrie L. Bourdow
CIK 1638989 · Acting CEO · last filed 2024-10-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.1K
Companies
3
Total Filings
39
Lifetime Open-Market Net
$115.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TRVN | President & CEO | 642,923 | $0.01 | $7.1K | $117.9K | 26 | 2023-12-15 |
| Nabriva Therapeutics plc (NBRV) Delisted | Director | 9,933 | $1.42 | $14.1K | -$2.4K | 8 | 2022-08-03 |
| Carisma Therapeutics Inc. (SESN) Delisted | Director | 40,000 | $12.58 | $503.0K | $0 | 4 | 2022-06-24 |
Recent Filings · Page 2 of 4
39 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-12-03 | TRVN | Grant (A) | +1,250,000 | $0 | EDGAR |
| 2021-08-04 | Nabriva Therapeutics plc (NBRV) Delisted | Sell (S) | −777 | -$932 | EDGAR |
| 2021-07-30 | Nabriva Therapeutics plc (NBRV) Delisted | Grant (A) | +17,500 | $0 | EDGAR |
| 2021-06-28 | TRVN | Buy (P) | +56,200 | $100.5K | EDGAR |
| 2021-05-05 | Carisma Therapeutics Inc. (SESN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-31 | TRVN | Tax (F) | −151,684 | -$344.3K | EDGAR |
| 2020-12-18 | TRVN | Grant (A) | +471,100 | $0 | EDGAR |
| 2020-12-09 | TRVN | Tax (F) | −132,934 | -$301.8K | EDGAR |
| 2020-07-31 | Nabriva Therapeutics plc (NBRV) Delisted | Grant (A) | +17,500 | $0 | EDGAR |
| 2020-05-08 | Carisma Therapeutics Inc. (SESN) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.